| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 25.711 | 13.006 | 12.301 | 26.856 | 20.827 | 25.747 | 30.387 | 33.571 | 45.482 |
| Total Income - EUR | 0 | 25.711 | 13.006 | 12.301 | 26.859 | 20.828 | 25.749 | 30.392 | 33.593 | 45.484 |
| Total Expenses - EUR | 3.519 | 15.787 | 8.721 | 6.259 | 20.452 | 22.510 | 28.708 | 27.731 | 31.978 | 45.396 |
| Gross Profit/Loss - EUR | -3.519 | 9.925 | 4.285 | 6.042 | 6.407 | -1.682 | -2.959 | 2.661 | 1.615 | 88 |
| Net Profit/Loss - EUR | -3.519 | 9.669 | 4.155 | 5.808 | 5.601 | -2.138 | -3.217 | 2.363 | 1.313 | -441 |
| Employees | 1 | 3 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Paraclinic Trend S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 181 | 6.032 | 5.112 | 4.215 | 3.346 | 2.510 | 1.699 | 947 | 189 | 0 |
| Current Assets | 291 | 5.817 | 9.275 | 12.359 | 27.039 | 33.090 | 31.014 | 29.842 | 29.062 | 28.466 |
| Inventories | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 514 | 6.852 | 1.160 | 2.176 | 9.710 | 18.992 | 18.188 |
| Cash | 255 | 5.817 | 9.275 | 11.844 | 20.187 | 31.930 | 28.838 | 20.132 | 10.070 | 10.278 |
| Shareholders Funds | -3.481 | 6.224 | 10.273 | 15.893 | 21.186 | 18.646 | 15.016 | 17.426 | 18.686 | 18.140 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.953 | 5.626 | 4.114 | 681 | 9.199 | 16.954 | 17.698 | 13.363 | 10.565 | 10.326 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Paraclinic Trend S.r.l.